Risk Factors Dashboard
Once a year, publicly traded companies issue a comprehensive report of their business, called a 10-K. A component mandated in the 10-K is the ‘Risk Factors’ section, where companies disclose any major potential risks that they may face. This dashboard highlights all major changes and additions in new 10K reports, allowing investors to quickly identify new potential risks and opportunities.
View risk factors by ticker
Search filings by term
Risk Factors - MBTC
-New additions in green
-Changes in blue
-Hover to see similar sentence in last filing
Item 1A. Risk Factors. Risk Factors.
As a smaller reporting company, we are not required to include risk factors in this Report. However, below is a partial list of material risks, uncertainties and other factors that could have a material effect on the Company and its operations:
| ● | we are a blank check company with no revenue; |
| ● | we may not be able to consummate the proposed initial business combination with Cognos on our expected timeframe or at all; |
15
| ● | our expectations around the performance of Cognos may not be realized; |
| ● | we may not be successful in retaining or recruiting required officers, key employees or directors following our initial business combination; |
| ● | our officers and directors may have difficulties allocating their time between the Company and other businesses and may potentially have conflicts of interest with our business or in approving our initial business combination; |
| ● | we may not be able to obtain additional financing to complete our initial business combination or reduce the number of shareholders requesting redemption; |
| ● | we may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time; |
| ● | trust account funds may not be protected against third party claims or bankruptcy; |
| ● | an active market for our public securities may not develop and our shareholders could have limited liquidity and trading opportunities; |
| ● | the availability to us of funds from interest income on the trust account balance may be insufficient to operate our business prior to the business combination; |
| ● | our financial performance following a business combination with Cognos may be negatively affected by Cognos’ lack of an established record of revenue, cash flows and experienced management; |
| ● | changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination; |
| ● | we may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us, which may include acting as a financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred underwriting commissions that will be released from the trust account only upon completion of an initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us, including, for example, in connection with the sourcing and consummation of an initial business combination; |
| ● | since our initial shareholders will lose their entire investment in us if our initial business combination is not completed (other than with respect to any public shares they may acquire), and because our sponsor, officers and directors may profit substantially even under circumstances in which our public shareholders would experience losses in connection with their investment, a conflict of interest may arise in determining whether a particular business combination target, including Cognos, is appropriate for our initial business combination; |
| ● | Changes in laws or regulations or how such laws or regulations are interpreted or applied, or a failure to comply with any laws or regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations; |
16
| ● | uncertainty concerning the applicability of the Investment Company Act to a SPAC (as further described in the March Proxy Statement); |
For the complete list of risks relating to our operations, see the sections titled “Risk Factors” contained in our Registration Statement, our Quarterly Reports on Form 10-Q, and our Definitive Proxy Statements on Schedule 14A (including the March Proxy Statement), each of which is filed with the SEC, and the corresponding “Risk Factors” section which will be contained in the proxy materials we file with the SEC and disseminate in connection with the approval of our initial business combination with Cognos.
Item 1B. Unresolved Staff Comments.
Not applicable.
Recently Filed
Click on a ticker to see risk factors
| Ticker * | File Date |
|---|---|
| USDW | 1 day, 10 hours ago |
| ORCL | 1 day, 11 hours ago |
| CASY | 1 day, 16 hours ago |
| POWW | 1 day, 21 hours ago |
| JRSH | 5 days, 10 hours ago |
| CMCAF | 5 days, 10 hours ago |
| CPBI | 5 days, 11 hours ago |
| MDT | 5 days, 11 hours ago |
| GRCE | 5 days, 20 hours ago |
| ETST | 5 days, 21 hours ago |
| IBATF | 6 days, 6 hours ago |
| SWBI | 6 days, 11 hours ago |
| LZB | 1 week ago |
| SNOA | 1 week ago |
| NKLR | 1 week, 1 day ago |
| CRDO | 1 week, 1 day ago |
| VTGN | 1 week, 1 day ago |
| AIOT | 1 week, 1 day ago |
| QUMS | 1 week, 1 day ago |
| CGC | 1 week, 1 day ago |
| GWAV | 1 week, 4 days ago |
| BF-A | 1 week, 4 days ago |
| RVSB | 1 week, 4 days ago |
| BKYI | 1 week, 4 days ago |
| IEHC | 1 week, 4 days ago |
| ONAR | 1 week, 5 days ago |
| FRD | 1 week, 5 days ago |
| SENEB | 1 week, 5 days ago |
| MH | 1 week, 5 days ago |
| AEMD | 1 week, 6 days ago |
| BARK | 1 week, 6 days ago |
| SJM | 2 weeks ago |
| ESSI | 2 weeks ago |
| NTCS | 2 weeks ago |
| NATH | 2 weeks ago |
| CETY | 2 weeks, 4 days ago |
| WRLD | 2 weeks, 5 days ago |
| OESX | 2 weeks, 5 days ago |
| LRHC | 2 weeks, 5 days ago |
| PYYX | 2 weeks, 5 days ago |
| ANVI | 2 weeks, 6 days ago |
| MLAB | 3 weeks ago |
| PETS | 3 weeks ago |
| UPYY | 3 weeks ago |
| SKFG | 3 weeks ago |
| HIVE | 3 weeks ago |
| IVF | 3 weeks ago |
| BRLS | 3 weeks ago |
| PRPH | 3 weeks, 1 day ago |
| GLSI | 3 weeks, 1 day ago |
